Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 18, 2026

Bonds Used to Be the Income Answer for Retirees. Then Came the Covered-Call ETF That Pays Over 7%.

View original at finance.yahoo.com
Bonds Used to Be the Income Answer for Retirees. Then Came the Covered-Call ETF That Pays Over 7%…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The premiums earned from selling options mathematically reduce the cost basis of each stock accordingly

    60% confidence
  • Low pandemic-era interest rates severely impacted retirees who rely on fixed-income investments for their retirement nest eggs

    60% confidence
  • YieldMax created an entire catalog of covered call ETFs with variations on the income model for both single stocks and portfolios, using volatility as a crucial component, featuring double-digit yields and monthly or weekly payouts

    60% confidence
  • JEPI has $45.61 billion in total assets under management

    60% confidence
  • The covered call ETF strategy for income generation was initially introduced by Invesco in 2007

    60% confidence
  • JEPI holds a portfolio of 120 to 130 low-volatility S&P 500 dividend stocks

    60% confidence
  • JEPI's strategy is predicated on slow stock volatilities, with the majority of ELNs expiring worthless, generating extra income beyond intrinsic stock appreciation

    60% confidence
  • The unnamed analyst who called NVIDIA in 2010 named a new top 10 stock list and JPMorgan Equity Premium Income ETF was not one of them

    60% confidence
  • 30-year mortgage rates started at 3.75% and fell to 3.0% by summer 2020 following central bank rate cuts

    60% confidence
  • 15% of JEPI assets are used to package calls into Equity Linked Notes that serve as synthetic out-of-the-money calls against the full portfolio

    60% confidence
  • JEPI sells near-term out-of-the-money calls and focuses on stocks that are not overly volatile, unlike some competitors such as YieldMax

    60% confidence
  • JEPI has delivered 8.38% annualized returns over 5 years

    60% confidence
  • The JP Morgan name does not necessarily mean JEPI is suitable for all investors

    60% confidence
  • JEPI generates an 8.29% yield through monthly payouts backed by Equity Linked Notes

    60% confidence
  • JEPI regularly advertises on Fox Business News and MSNBC

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com